Showing results (31-40 of 782) with videos related to
Sort By:
Pageof 79
Kidney International. Supplement|December 1, 2010
Non-immune interventions to protect kidney allografts in the long termPaolo Cravedi, Norberto Perico, Giuseppe RemuzziNephron|May 24, 2018
Disparities in Chronic Kidney Disease Prevalence among Males and Females in 195 Countries: Analysis of the Global Burden of Disease 2016 StudyBoris Bikbov, Norberto Perico, Giuseppe Remuzzi, et al.BMC Medical Research Methodology|October 21, 2018
A comparison of metrics and performance characteristics of different search strategies for article retrieval for a systematic review of the global epidemiology of kidney and urinary diseasesBoris Bikbov, Norberto Perico, Giuseppe Remuzzi, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 5, 2025
The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient CareMonica Cortinovis, Norberto Perico, Giuseppe RemuzziPharmacological Reviews|May 18, 2025
Innovative therapeutics for renoprotection: Where we areMonica Cortinovis, Norberto Perico, Giuseppe RemuzziSeminars in Nephrology|October 29, 2013
Overview of complement activation and regulationMarina Noris, Giuseppe RemuzziNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2023
C3G and Ig-MPGN-treatment standardMarina Noris, Giuseppe RemuzziKidney International|October 31, 2020
Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule?Marina Noris, Giuseppe RemuzziKidney International|October 20, 2024
Looking into the cholesterol crystal ball: is complement the answer?Marina Noris, Giuseppe RemuzziKidney International|June 24, 2019
Terminal complement effectors in atypical hemolytic uremic syndrome: C5a, C5b-9, or a bit of both?Marina Noris, Giuseppe RemuzziPageof 79